Clinical Trial Update: Ketamine for Depression Relapse Prevention Following ECT [EARLY_Phase 1]

View source ↗

Summary

Early-phase trial investigating ketamine for relapse prevention of depression after electroconvulsive therapy has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: St Patrick's Hospital, Ireland | Conditions: Depression | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2021-05-06